4 h. ago Hexaware Tech In Focus As Jefferies Initiates Coverage With 'Buy' Rating: Check Target Price

Hexaware offers a growth charecteristic of a mid-sized IT firms with quality metrics rivaling large IT firms, the Jefferies report states

Events

6 h. ago Dreamfolks Shares In Focus After Travel Food Services Terminates Key Contract

The termination follows unsuccessful attempts to renegotiate commercial terms and take effect on Sept. 15.

Politics

4 d. ago PCOS Awareness Month: You Are Not Alone, Experiences From Women With PCOS

PCOS Awareness Month 2025: Beyond statistics and campaigns, lived experiences bring the reality of PCOS into sharp focus. Read on as we share personal diaries of women living with PCOS.

Events

4 d. ago Suzlon Energy Shares Up 2% As Motilal Oswal Initiates Coverage With 'Buy'

Shares of Suzlon Energy last traded 2.02% higher at Rs 57.57 apiece on the BSE. Motilal Oswal is bullish on the stock over order bool volume.

Politics

7 d. ago Amber Enterprises Gets PL Capital's 'Buy' Rating As It Initiates Coverage

PL Capital is positive on Amber Enterprises and initiates coverage with a 'Buy' call citing strong growth outlook and diversification plans.

Politics

1 week ago Brigade Enterprises Gets Yes Securities' 'Buy' Rating As It Initiates Coverage; Sees 24% Upside

Coming four-quarters to be launch heavy for Brigade Enterprises, expect 20%+ pre-sales growth; hence Yes Securities assigns Buy call.

Politics

1 week ago Motilal Oswal Initiates Coverage On These Three IT Stocks With Buy And Sell Rating

KPIT leads amid software shift, peers face margin pressures, adds Motilal Oswal

Politics

1 week ago Divi's Labs Shares In Focus As Jefferies Upgrades To 'Buy', Eyes 16% Upside On Sustained Growth Momentum

Divi's Laboratories' custom synthesis segment has clocked strong year-on-year growth of 19% in the financial year 2025. Sacubitril Valsartan has led the growth in this segment, Jefferies said.

Politics

1 week ago Cohance Lifesciences Shares In Focus As Jefferies Initiates Coverage With 'Buy' Rating: Check Target Price

Cohance is well-placed to benefit from Antibody Drug Conjugate industry tailwinds, according to Jefferies.

Economics

2 w. ago Sagility India Shares In Focus As Kotak Securities Initiates Coverage With 'Buy' Rating

Kotak Securities highlighted that the company has scope of enhanced platform capabilities and better scale-up of new clients.

Politics

2 w. ago BSE Can Face 6% Hit In Profit On Every 10% Drop In Options Premium Average Daily Turnover: UBS

UBS had initiated coverage on India's second-largest stock exchange nearly five months ago and continues to remain bullish on the company.

Events

3 w. ago Indian shares muted as financials offset IT gains; US, domestic CPI in focus

Indian shares muted as financials offset IT gains; US, domestic CPI in focus  Reuters

Economics

3 w. ago Prestige Estate Shares Gets Yes Securities' 'Buy' Rating As It Re

The brokerage projects a 23% upside in the stock from current levels.

Politics